Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

WeRide GENESIS wins top AI awards, boosting autonomous driving tech and global deployment.

Market News
25 Jun 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

WeRide's autonomous driving platform, WeRide GENESIS, won the 2026 AI Breakthrough Award for Overall Gen-AI Solution of the Year and the 2026 ATTI Simulation Innovation Award. This recognition highlights its advanced physical AI capabilities that enable high-fidelity simulation, reducing data costs by over 75% and accelerating autonomous vehicle development. Deployed in over 40 cities across 12 countries, WeRide GENESIS supports fully driverless operations and mass-production ADAS systems, driving global expansion and innovation in autonomous driving technology.

More News

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...

Company Fundamentals
Neutral
1 hour ago
Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...

Company Fundamentals
Neutral
1 hour ago
Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...

Market News
Neutral
1 hour ago
Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...

Market News
Neutral
1 hour ago
Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App